These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cibenzoline for symptomatic ventricular arrhythmias: a prospective, randomized, double-blind, placebo controlled trial and a long term open label study. Lee MA; Fenster PE; Garcia ZM; Kipps JE; Huang SK Can J Cardiol; 1989 Sep; 5(6):295-8. PubMed ID: 2477130 [TBL] [Abstract][Full Text] [Related]
3. Cibenzoline for high-frequency ventricular arrhythmias: a short-term comparison with quinidine and a long-term follow-up. Palakurthy PR; Maldonado C; Sohi G; Flowers NC J Clin Pharmacol; 1987 Apr; 27(4):283-7. PubMed ID: 3680585 [TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction. Seals AA; Haider R; Leon C; Francis M; Young JB; Roberts R; Pratt CM Circulation; 1987 Apr; 75(4):800-8. PubMed ID: 3549044 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias. Browne KF; Prystowsky EN; Zipes DP; Chilson DA; Heger JJ J Am Coll Cardiol; 1984 Mar; 3(3):857-64. PubMed ID: 6693656 [TBL] [Abstract][Full Text] [Related]
6. Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia. Hoffmann E; Mattke S; Haberl R; Steinbeck G J Cardiovasc Pharmacol; 1993 Jan; 21(1):95-100. PubMed ID: 7678686 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oral cibenzoline for ventricular arrhythmias. Klein RC; Horwitz LD; Rushforth N Am J Cardiol; 1986 Mar; 57(8):592-7. PubMed ID: 3953445 [TBL] [Abstract][Full Text] [Related]
8. Cibenzoline for treatment of ventricular arrhythmias: a double-blind placebo-controlled study. Kostis JB; Krieger S; Moreyra A; Cosgrove N J Am Coll Cardiol; 1984 Aug; 4(2):372-7. PubMed ID: 6376595 [TBL] [Abstract][Full Text] [Related]
9. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias. Mohiuddin SM; Woodruff MP; Esterbrooks DJ; Mooss AN; Hansen JM; Hilleman DE J Cardiovasc Pharmacol; 1989 Apr; 13(4):525-9. PubMed ID: 2470988 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study. Wasty N; Saksena S; Barr MJ Am Heart J; 1985 Dec; 110(6):1181-8. PubMed ID: 4072875 [TBL] [Abstract][Full Text] [Related]
14. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia. Rothbart ST; Saksena S Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898 [TBL] [Abstract][Full Text] [Related]
15. Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias. Harron DW; Brogden RN; Faulds D; Fitton A Drugs; 1992 May; 43(5):734-59. PubMed ID: 1379150 [TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic use of cibenzoline, a new class 1 antiarrhythmic agent with class 3 and 4 properties, in patients with recurrent ventricular tachycardia. Cocco G; Strozzi C; Pansini R; Rochat N; Bulgarelli R; Padula A; Sfrisi C; Kamal Al Yassini A Eur Heart J; 1984 Feb; 5(2):108-14. PubMed ID: 6723683 [TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of intravenous cibenzoline for acute termination of spontaneous sustained ventricular tachycardia. Cibenzoline and spontaneous VT. Chevalier P; Dacosta A; Chalvidan T; Bonnefoy E; Kirkorian G; Isaaz K; Touboul P Int J Cardiol; 1998 May; 64(3):265-70. PubMed ID: 9672407 [TBL] [Abstract][Full Text] [Related]